Forecast

Buy	0
Hold	2
Sell	0

News Go to news feed

Conceivable Life Sciences raises $50 million to bring AI and robotics to IVF

Conceivable Life Sciences closed a $50 million Series A to scale its Aura platform, which combines AI algorithms with robotic hardware to automate and standardize the IVF workflow from dish and sperm preparation to fertilization and incubation. The round is led by investors including ARTIS ventures, Stride and ACME ventures. An initial study using Aura resulted in 18 healthy births and a larger ~120‑participant study is ongoing, with a planned commercial launch early next year. The funding will be used to advance clinical studies and prepare the platform for market deployment. » More on forbes.com

Historical dividends Dividends

All dividend metrics All metrics

In 2024, ARTIS REAL EST.INV.TR.UTS has already paid €0.0345 in dividends. The last payout was in February 2024.

Financials

In the last quarter, ARTIS REAL EST.INV.TR.UTS had revenue of €34.82M and net profit of -€68.31M

(EUR)	Dec 2025	YoY
Revenue	34.82M	-
Gross profit	16.45M	-
Net profit	-68.31M	-
EBITDA	-58.75M	-

Fundamentals

Metric	Value
Market capitalization	€536.73M
Number of shares	95.97M
52-week high/low	€6.15 - €3.63
Dividends	No
Beta	0.67
P/E ratio	-15.53
PEG ratio	0.28
P/B ratio	0.60
P/S ratio	4.68

Company profile

Artis ist ein diversifizierter kanadischer Real Estate Investment Trust, der in Industrie- und Büroimmobilien in Kanada und den Vereinigten Staaten investiert. Seit 2004 hat Artis eine aggressive, aber disziplinierte Wachstumsstrategie verfolgt und ein Portfolio von Gewerbeimmobilien in ausgewählten Märkten in Kanada und den Vereinigten Staaten aufgebaut. Zum 30. September 2020 umfassten die Gewerbeimmobilien von Artis rund 23,8 Millionen Quadratfuß vermietbare Fläche.

Name	ARTIS REAL EST.INV.TR.UTS
CEO	Kim Riley
Headquarters	Winnipeg, mb Canada
Website	artisreit.com
Sector	Real Estate
Industry	Diversified REITs
IPO	09/17/2007
Employees	143